Skip to main content
Ocumension Therapeutics logo

Ocumension Therapeutics — Investor Relations & Filings

Ticker · 1477 ISIN · KYG674111011 LEI · 5493000USURI3SIL4Z85 HKEX Manufacturing
Open in API
Filings indexed 459 across all filing types
Latest filing 2024-07-16 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1477

About Ocumension Therapeutics

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company dedicated to the research, development, and commercialization of first-in-class or best-in-class therapeutics. The company focuses on providing comprehensive treatment solutions for Chinese patients suffering from ocular diseases. Ocumension has established a complete ophthalmic drug product line, currently holding 20 drug assets covering both anterior and posterior segments of the eye. Its portfolio addresses major conditions such as chronic non-infectious uveitis, infective and allergic conjunctivitis, and diabetic macular edema. The company employs a strategy combining continuous scientific innovation, independent R&D, and strategic alliances to sustain the supply of innovative products across the ophthalmology field.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT BIOLOGIC LICENSE APPLICATION FOR OT-702 ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Ocumension Therapeutics regarding the acceptance of a biologic license application (BLA) for a drug by the National Medical Products Administration in China. It provides detailed information about the drug, clinical trial results, and regulatory status. There is no indication that this is a full financial report, audit report, earnings release, or any other formal regulatory filing type. The document is an announcement of a business update related to regulatory approval and clinical progress, not a financial or governance report. It is not a report publication announcement since it contains substantive content rather than just a notice of report availability. Therefore, the best fitting category is a Regulatory Filing (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-07-16 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2024
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report concerning movements in securities, specifically focusing on share capital, issued shares, share options, warrants, and other share-related arrangements for Ocumension Therapeutics. It includes confirmations pursuant to Hong Kong Stock Exchange listing rules about the authorization and compliance of these share movements. The document is structured as a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting on share capital and share issuance activities for the month ended 30 June 2024. It does not contain financial statements, earnings data, management discussion, or audit information. It is not an announcement of a report but a detailed regulatory filing about share capital movements and confirmations. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-07-04 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 20, 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from the Annual General Meeting (AGM) held on June 20, 2024. It details the voting outcomes on various resolutions including adoption of audited financial statements, re-election of directors, appointment of auditors, and share issuance mandates. The document does not contain the full financial statements or detailed reports but rather the official voting results of the AGM. It references the Notice and Circular but does not include them. The length is 7635 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-06-20 English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2024
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report on movements in securities for a company listed on the Hong Kong Stock Exchange. It includes information on authorized and issued share capital, share options, warrants, convertibles, other agreements to issue shares, and repurchases of shares. The document is structured as a regulatory return to the exchange, confirming compliance with listing rules and providing detailed share capital movements for the month ended 31 May 2024. It is not a financial report like an annual or interim report, nor is it an earnings release or management discussion. It is a regulatory filing related to share capital and securities movements, typical of filings under exchange listing rules. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (12,654 characters) and detailed content support this classification with high confidence.
2024-06-06 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2024
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report on movements in securities for Ocumension Therapeutics, including authorized share capital, issued shares, share options, warrants, and repurchases. It is addressed to the Hong Kong Exchanges and Clearing Limited and follows the format of a regulatory return under the Exchange Listing Rules. The content focuses on share capital changes, share options, warrants, and confirmations related to securities issuance and repurchase. There is no financial performance data, earnings information, or management discussion. The document is not an announcement of a report but a regulatory filing itself. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-06-03 English
Documents on Display
Regulatory Filings Classification · 95% confidence The document is a placeholder message from the Hong Kong Exchanges and Clearing Limited stating that the requested document has been removed by the issuer. Since it does not contain any substantive financial or corporate information and serves as a system-generated notice regarding a missing filing, it falls under the general regulatory announcement category.
2024-05-23 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.